Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide

Journal of Neuroscience

Volumn 17, Issue 5, 1997, Pages 1683-1690

  Pappolla, Miguel A ^a,f   Sos, Melisa ^b   Omar, Rawhi A ^c   Bick, Roger J ^b   Hickson Bick, Diane L M ^b   Reiter, Russel J ^d   Efthimiopoulos, Spiros ^e   Robakis, Nickolaos K ^e  

^a UNIVERSITY OF SOUTH ALABAMA   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c University of Louisville School of Medicine   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF SOUTH ALABAMA MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; antioxidants; A toxicity; melatonin; neuronal cells; oxidative stress

Indexed keywords

AMYLOID; FREE RADICAL; MELATONIN; PINEAL BODY HORMONE;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; HORMONE RELEASE; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; TUMOR CELL CULTURE;

EID: 0031053554     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.17-05-01683.1997     Document Type: Article

References (60)

1. Anderson JP, Sambamurti K, Esch FS, Keim PS, Lieberburg I, Robakis NK (1991) Exact cleavage site of Alzheimer amyloid precursor in neuronal PC12 cells. Neurosci Lett 128:126-129.
2. Behl C, Davis JB, Cole GM, Schubert D (1992) Vitamin E protects nerve cells from amyloid protein toxicity. Biochem Biophys Res Commun 186:944-950.
3. Behl C, Davis JB, Klier FG, Schubert D (1994a) Amyloid beta peptide induces necrosis rather than apoptosis. Brain Res 645:253-264.
4. Behl C, Davis JB, Lesley R, Schubert D (1994b) Hydrogen peroxide mediates amyloid protein toxicity. Cell 77:817-827.
5. Benitez-King G, Anton-Tay F (1993) Calmodulin mediates melatonin cytoskeletal effects [Review]. Experientia 49:635-641.
6. Burdick D, Soregan B, Kwon M, Kosmoski J, Knauer M, Henschen A, Yates J, Cotman CW, Glabe C (1992) Assembly and aggregation properties of synthetic Alzheimer's A4/amyloid peptide analogs. J Biol Chem 267:546-554.
7. Busciglio J, Lorenzo A, Yankner BA (1992) Methodological variables in the assessment of beta-amyloid neurotoxicity. Neurobiol Aging 13:609-612.
8. Busciglio J, Yeh J, Yankner BA (1993) Beta-amyloid neurotoxicity in human cortical culture is not mediated by excitotoxins. J Neurochem 61:1565-1568.
9. Butterfield DA, Hensley K, Harris M, Mattson M, Carney J (1994) Beta-amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease. Biochem Biophys Res Commun 200:710-715.
10. Chartier-Harlin MC, Crawford F, Houlden H, Warren A, Hughes D, Fidani L, Goate A, Rossor M, Roques P, Hardy J, Mullan M (1991) Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature 353:844-846.
11. Copani A, Bruno V, Battaglia G, Leanza G, Pellitteri R, Russo A, Stanzani S, Nicoletti F (1995) Activation of metabotropic glutamate receptors protects cultured neurons against apoptosis induced by beta-amyloid peptide. Mol Pharmacol 47:890-897.
12. Dori D, Casale G, Solerte SB, Fioravanti M, Migliorati G, Cuzzoni G, Ferrari E (1994) Chrono-neuroendocrinological aspects of physiological aging and senile dementia. Chronobiology 21:121-126.
13. Furuta A, Price DL, Pardo C, Troncoso JC, XU Z-S, Taniguchi N, Martin LJ (1995) Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus. Am J Pathol 146:357-367.
14. Glenner GG, Wong CW (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120:885-890.
15. Goodman Y, Mattson MP (1994) Secreted forms of beta-amyloid precursor protein protect hippocampal neurons against amyloid beta-peptide-induced oxidative injury. Exp Neurol 128:1-12.
16. 1-42 peptide is cell type-dependent. J Neurochem 65:292-300.
17. Haass C, Schlossmacher MG, Hung AY, Vigo-Pelfrey C, Mellon A, Ostaszewski BL, Lieberburg I, Koo EH, Schenk D, Teplow DB, Selkoe DJ (1992) Amyloid peptide is produced by cultured cells during normal metabolism. Nature 359:322-324.
18. Harris ME, Hensley K, Butterfield DA, Leedle RA, Carney JM (1995) Direct evidence of oxidative injury produced by the Alzheimer's beta-amyloid peptide (1-40) in cultured hippocampal neurons. Experimental Neurol 131:193-202.
19. 2+ pump ATPase of human red blood cell membranes. In: Basic techniques for transmission electron microscopy. San Diego: Academic.
20. Hensley K, Carney JM, Mattson MP, Aksenova M, Harris M, Wu JF, Floyd RA, Butterfield DA (1994) A model for beta-amyloid aggregation and neurotoxicity based on free-radical generation by the peptide: relevance to Alzheimer disease. Proc Natl Acad Sci USA 91:3270-3274.
21. Huerto-Delgadillo L, Anton-Tay F, Benitez-King G (1994) Effects of melatonin on microtubule assembly depend on hormone concentration: role of melatonin as a calmodulin antagonist. J Pineal Res 17:55-62.
22. Hyman BT, West HL, Gomez-Isla T, Mui S (1985) Quantitative neuropathology in Alzheimer's disease: neuronal loss in high-order association cortex parallels dementia. In: Research advances in Alzheimer's disease and related disorders (Iqbal K, Mortimer JA, Windblad B, Wisniewski HM, eds), pp 453-460. New York: Wiley.
23. Iguchi H, Kato K, Ibayashi H (1982) Age-dependent reduction in serum melatonin concentrations in healthy subjects. J Clin Endocrinol Metab 55:27-29.
24. Kennedy AM, Newman S, McCaddon A, Ball J, Roques P, Mullan M, Hardy J, Chartier-Harlin MC, Frackowiak RS, Warrington EK (1993) Familial Alzheimer's disease. A pedigree with a mis-sense mutation in the amyloid precursor protein gene (amyloid precursor protein 717 valine→glycine). Brain 116:309-324.
25. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH (1994) Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84:1415-1420.
26. Le W-D, Colom LV, Xie W-J, Smith G, Alexianu M, Appel SH (1995) Cell death induced by amyloid 1-40 in MES 23.5 hybrid clone: the role of nitric oxide and NMDA-gated channel activation leading to apoptosis. Brain Res 686:49-60.
27. 2+. Oncogene 12:2259-2266.
28. 2+ homeostasis and cell death. J Neurosci 15:6239-6249.
29. Mattson MP (1994) Calcium and neuronal injury in Alzheimer's disease. Contributions of beta-amyloid precursor protein mis-metabolism, free radicals, and metabolic compromise [Review]. Ann NY Acad Sci 747:50-76.
30. Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel RE (1992) Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 12:376-389.
31. 2+ homeostasis in Alzheimer's disease. Trends Neurosci 16:409-414.
32. Menendez-Pelaez A, Poeggeler B, Reiter RJ, Barlow-Walden L, Pablos MI, Tan D (1993) Nuclear localization of melatonin in different mammalian tissues: immunocytochemical and radioimmunoassay evidence. J Cell Biochem 53:373-382.
33. Minta A, Kao JP, Tsien RY (1985) Fluorescent indicators for cytosolic calcium based on rhodamine and fluorescein chromophores. J Biol Chem 264:8171-8178.
34. Mishima K, Okawa M, Hishikawa Y, Hozumi S, Hori H, Takahashi K (1994) Morning bright light therapy for sleep and behavior disorders in elderly patients with dementia. Acta Psychiatr Scand 89:1-7.
35. Nicotera P, Bellomo G, Orrenius S (1992) Calcium-mediated mechanisms in chemically induced cell death. Annu Rev Pharmacol Toxicol 32:449-470.
36. Omar RA, Pappolla MA (1993) Oxygen free radicals as inducers of heat shock protein synthesis in cultured human neuroblastoma cells: relevance to neurodegenerative disease. Eur Arch Psychiatry Clin Neurosci 651:1-6.
37. Omar RA, Yano S, Kikkawa Y (1987) Antioxidant enzymes and survival of normal and SV-10-transformed mouse embryo cells after hyperthermia. Cancer Res 47:3473-3476.
38. Pappolla MA, Robakis NK (1995) Neuropathology and molecular biology of Alzheimer's disease. In: Perspectives in behavioral medicine, Alzheimer's disease, and AIDS (Stein M, Baum M, eds). San Diego: Academic.
39. Pappolla MA, Omar RA, Kim KS, Robakis NK (1992) Immunohistochemical evidence of oxidative stress in Alzheimer's disease. Am J Pathol 140:621-628.
40. Pappolla MA, Sos M, Omar RA, Sambamurti K (1996) The heat shock/ oxidative stress connection. Relevance to Alzheimer's disease. Mol Chem Neuropathol 28:21-34.
41. Pierpaoli W (1991) The pineal gland: a circadian or seasonal aging clock? [Editorial]. Aging (Milano) 3:99-101.
42. Pierpaoli W, Dall'Ara A, Pedrinis E, Regclson W (1991) The pineal control of aging. The effects of melatonin and pineal grafting on the survival of older mice. Ann NY Acad Sci 621:291-313.
43. Pike CJ, Burdick D, Walencewicz AJ, Glabe CG, Cotman CW (1993) Neurodegeneration induced by β-amyloid peptide in vitro: the role of peptide assembly state. J Neurosci 13:1676-1687.
44. Pool M, Kavanagh TJ, Kang HC, Haugland RP, Rabinovitch PS (1991) Flow cytometric analysis of cell cycle-dependent changes in cell thiol level by combining a new laser dye with Hoechst 33342. Cytometry 12:184-187.
45. Reiter RJ (1995) The pineal gland and melatonin in relation to aging: a summary of the theories and of the data [Review]. Exp Gerontol 30:199-212.
46. Robakis NK (1994) Amyloid and amyloid precursor protein: chemistry, molecular biology, and neuropathology. In: Alzheimer disease (Terry RD, Katzman R, Bick KL, eds), p 317-326. New York: Raven.
47. Robakis NK, Ramakrishna N, Wolfe G, Wisniewski HM (1987) Molecular cloning and characterization of a cDNA encoding the cerebrovascular and the neuritic plaque amyloid peptides. Proc Natl Acad Sci USA 84:4190-4194.
48. Rohn TT, Hinds TR, Vincenzi FF (1993) Ion transport, ATPases a target for free radical damage. Biochem Pharmacol 46:525-534.
49. Rothstein JD, Bristol LA, Hosler B, Brown Jr RH, Kuncl RW (1994) Chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons. Proc Natl Acad Sci USA 91:4155-4159.
50. Sambamurti K, Shioi J, Anderson JP, Pappolla MA, Robakis NK (1992) Evidence for intracellular cleavage of the Alzheimer's amyloid precursor in PC12 cells. J Neurosci Res 33:319-329.
51. Shoji M, Golde TE, Ghiso J, Cheung TT, Estus S, Shatter LM, Cai X-D, McKay DM, Tinter R, Frangione B, Younkin SG (1992) Production of the Alzheimer amyloid protein by normal proteolytic processing. Science 258:126-129.
52. Skene DJ, Vivien-Roels B, Sparks DL, Hunsaker JC, Pevet P, Ravid D, Swaab DF (1990) Daily variation in the concentration of melatonin and 5-methoxytryptophol in the human pineal gland: effect of age and Alzheimer's disease. Brain Res 528:170-174.
53. Smith MA, Kutty RK, Richey PL, Yan SD, Stern D, Chader GJ, Wiggert B, Petersen Smith RB, Perry G (1994) Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. Am J Pathol 145:42-47.
54. Souetre E, Salvati E, Krebs B, Belugou JL, Darcourt G (1989) Abnormal melatonin response to 5-methoxypsoralen in dementia. Am J Psychiatry 146:1037-1040.
55. Vermes I, Haanen C, Steffens-Nakken H, Reutclingsperger C (1995) A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein-labeled annexin V. J Immunol Methods 184:39-51.
56. 2+-binding protein ALG-2 and Alzheimer's disease gene ALG-3. Science 721:521-525.
57. Weidemann A, Konig G, Bunke D, Fisher P, Salbaum JM, Masters CL, Beyreuther K (1989) Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell 57:115-126.
58. 2+ channel blockers attenuate beta-amyloid peptide toxicity to cortical neurons in culture. J Neurochem 62:372-375.
59. Yankner DA, Duffy LK, Kirschner DA (1990) Neurotrophic and neurotoxic effects of amyloid protein: reversal by tachykinin neuropeptides. Science 250:279-282.
60. Zhang Z, Drzewiecki GH, Hom JP, May PC, Hyslop PA (1994) Human cortical neuronal (HCN) cell lines: a model for amyloid beta neurotoxicity. Neurosci Lett 177:162-164.